Frontier Medicines
Focus: Frontier Medicines is a public-stage biotech company leveraging a proprietary chemoproteomics platform for drug discovery, currently focused on oncology with early-stage pipeline programs.
Profile data last refreshed 17h ago · AI intelligence enriched 2w ago
Funding Stage
PUBLIC
Open Jobs
1-2 this month
Stable — net -2 jobs in 30d
0 added, 2 removed. Backfill posture.
Should You Work at Frontier Medicines?
AI assessmentFrontier Medicines offers a rare opportunity to build cutting-edge oncology science on a novel platform, but requires tolerance for early-stage execution risk and limited near-term growth.
Why Work Here
- Access to differentiated chemoproteomics discovery platform that targets 'undruggable' disease mechanisms, positioning you at the frontier of oncology innovation
Data completeness
4/9 — Basic
Company HealthSolid
Pipeline
Early-stage
1 total
LOE Risk
Protected
No near-term cliffs
Hiring
Slowing
Jobs decreasing
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
PHASE_1_2
Clinical Trials (1)
NCT06244771A Study Evaluating FMC-376 in Participants With KRAS G12C Mutated Solid Tumors
Phase 1/2Help build intelligence for Frontier Medicines
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.